584 — AJJ Medtech Holdings Income Statement
0.000.00%
Last trade - 00:00
- SG$5.51m
- SG$7.91m
- SG$1.62m
2019 December 31st | R2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.18 | 0.683 | 0.319 | 0.596 | 1.61 |
Cost of Revenue | |||||
Gross Profit | — | 0.683 | 0.271 | 0.312 | 0.699 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1.13 | 3.39 | 1.98 | 4.52 | 4.12 |
Operating Profit | -0.949 | -2.71 | -1.66 | -3.93 | -2.5 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -1.06 | -2.81 | -1.74 | -3.98 | -2.56 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.955 | -2.8 | -1.73 | -3.7 | -2.56 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -0.955 | -2.77 | -1.7 | -4.24 | -2.53 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.955 | -2.77 | -1.7 | -4.24 | -2.53 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.001 | -0.004 | -0.002 | -0.003 | -0.003 |